Mechanisms of confluence-dependent expression of CD26 in colon cancer cell lines
<p>Abstract</p> <p>Background</p> <p>CD26 (dipeptidyl peptidase IV, DPPIV) is a 110 kDa surface glycoprotein expressed in most normal tissues, and is a potential novel therapeutic target for selected cancers. Our work evaluates the mechanism involved in confluence-depen...
Main Authors: | Morimoto Chikao, Ohnuma Kei, Urasaki Yasuyo, Havre Pamela A, Abe Masako, Dang Long H, Dang Nam H |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-02-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/11/51 |
Similar Items
-
CD9 negatively regulates CD26 expression and inhibits CD26-mediated enhancement of invasive potential of malignant mesothelioma cells.
by: Toshihiro Okamoto, et al.
Published: (2014-01-01) -
Localization of CD26/DPPIV in nucleus and its nuclear translocation enhanced by anti-CD26 monoclonal antibody with anti-tumor effect
by: Sakamoto Michiie, et al.
Published: (2009-06-01) -
Clinical significance of soluble CD26 in malignant pleural mesothelioma.
by: Nobukazu Fujimoto, et al.
Published: (2014-01-01) -
Comparative Study of Regulatory T Cell Function of Human CD25+CD4+ T Cells from Thymocytes, Cord Blood, and Adult Peripheral Blood
by: Wakae Fujimaki, et al.
Published: (2008-01-01) -
Development of novel monoclonal antibodies with specific binding affinity for denatured human CD26 in formalin-fixed paraffin-embedded and decalcified specimens.
by: Ryo Hatano, et al.
Published: (2019-01-01)